Finance

Lists
DWTX:NASDAQ
Dogwood Therapeutics Inc
$1.11
-0.89%
(-0.0100) 1D
Nov 13, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DWTX...
Open
$1.14
High
$1.19
Low
$1.10
Mkt. cap
42.43M
Avg. vol.
98.76K
Volume
74.65K
52-wk high
$7.04
52-wk low
$0.90
EPS
-$8.95
Beta
2.08
Shares outstanding
38.23M
No. of employees
8
Open
$1.14
High
$1.19
Low
$1.10
Mkt. cap
42.43M
Avg. vol.
98.76K
Volume
74.65K
52-wk high
$7.04
52-wk low
$0.90
EPS
-$8.95
Beta
2.08
Shares outstanding
38.23M
No. of employees
8
News stories
From web sources and news partners
About Dogwood Therapeutics Inc
CEO-
Employees8
Founded2012
HeadquartersAlpharetta, Georgia, United States
SectorHealth Care
IndustryBiotechnology
Websitedwtx.com
Analyst ratings
Based on 2 analysts giving stock ratings to DWTX in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for DWTX in the last 3 months.
Highest
Current $1.11
$15.00 (+1,251.35%)
Average
$13.50 (+1,116.22%)
Lowest
$12.00 (+981.08%)
Analyst
Recommendation
Action
Price target
Projected
Date
Sean Lee CFA
H.C. Wainwright
Buy
Reiterated
$12.00
+981.1%
11/06/2026
Jason McCarthy
Maxim Group
Buy
Reiterated
$15.00
+1,251.4%
09/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
100.00K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.34M
2.67M
3.25M
3.35M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.47M
2.39M
1.61M
1.55M
Operating expense
3.81M
5.06M
4.86M
4.90M
Total operating expenses
3.81M
5.06M
4.86M
4.90M
Operating income
-3.81M
-5.06M
-4.86M
-4.80M
Other non operating income
-
-
-
-46.07K
EBT including unusual items
-3.75M
-4.99M
-14.01M
-4.88M
EBT excluding unusual items
-3.75M
-4.99M
-4.82M
-4.88M
Income tax expense
31.84K
1.19K
-2.48M
-839.00
Effective tax rate
-0.85%
-0.02%
17.71%
0.02%
Other operating expenses
-
-
-
-
Net income
-3.78M
-4.99M
-11.53M
-4.88M
Net profit margin
-
-
-
-4,882.94%
Earnings per share
-
-
-
-
Interest and investment income
52.07K
77.35K
66.35K
-
Interest expense
-
-
-
-
Net interest expenses
52.07K
77.35K
66.35K
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.81M
-5.06M
-4.85M
-4.80M
Gain or loss from assets sale
2.73K
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps